Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms

Clinical significance of genetic aberrations in secondary acute myeloid leukemia

(2012) Jelena D. Milosevic et al.   AMERICAN JOURNAL OF HEMATOLOGY

Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment

(2012) Jun Ho Yi et al.   ANNALS OF HEMATOLOGY

Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis

(2012) Barbara Pressato et al.   BRITISH JOURNAL OF HAEMATOLOGY

SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3

(2012) Daniel Nowak et al.   GENES CHROMOSOMES & CANCER

A clinical algorithm predicts hematological complications in Shwachman–Diamond syndrome?

(2012) Johnson M Liu   Expert Review of Hematology

Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies

(2012) Michiko Okada et al.   Cancer Genetics

Additional Genomic Aberrations Identified by Single Nucleotide Polymorphism Array-Based Karyotyping in an Acute Myeloid Leukemia Case with Isolated del(20q) Abnormality

(2012) Chorong Hahm et al.   Annals of Laboratory Medicine

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

(2011) T. Klampfl et al.   BLOOD

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms

(2011) K L Rice et al.   Blood Cancer Journal

Evaluating chromosomal mosaicism by array comparative genomic hybridization in hematological malignancies: the proposal of a formula

(2011) Roberto Valli et al.   Cancer Genetics

A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes

(2011) Ruth N. MacKinnon et al.   Cancer Genetics

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes

(2011) Kathryn A. Kolquist et al.   Cancer Genetics

Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells

(2011) Roberto Valli et al.   Molecular Cytogenetics

Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia

(2011) Renu Bajaj et al.   Molecular Cytogenetics

Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia

(2010) B. Parkin et al.   BLOOD

High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes

(2010) Ioana Borze et al.   CANCER GENETICS AND CYTOGENETICS

The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion

(2010) Ruth N. MacKinnon et al.   GENES CHROMOSOMES & CANCER

Clonal heterogeneity in childhood myelodysplastic syndromes-Challenge for the detection of chromosomal imbalances by array-CGH

(2010) Inka Praulich et al.   GENES CHROMOSOMES & CANCER

Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML

(2010) Vincenza Barresi et al.   LEUKEMIA RESEARCH

Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes

(2010) Marilyn L Slovak et al.   Molecular Cytogenetics

The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies

(2009) Emanuela Maserati et al.   BRITISH JOURNAL OF HAEMATOLOGY

Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics

(2009) S Heinrichs et al.   LEUKEMIA

Acquired mutations in TET2 are common in myelodysplastic syndromes

(2009) Saskia M C Langemeijer et al.   NATURE GENETICS

Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F

(2008) F. X. Schaub et al.   BLOOD

High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival

(2008) D. T. Starczynowski et al.   BLOOD